NEW RESEARCH STUDY
Quality Management System Trends in Life Sciences
A series of 4 executive briefings
Did you know?
- 93% of companies with QMS report recurring issues after a CAPA is closed
- 67% of companies with QMS saw no CAPA improvement
- 66% of companies with QMS report no global view with suppliers
- Most companies want to go beyond documenting quality issues to preventing them, but their current QMS holds them back
You can learn more about this and other key findings and analysis in a recent research study by Industry Analyst firm Axendia. The study, titled “Quality Management System Trends in Life Sciences”, identifies the state of current QMS implementations across Life Sciences and their impact on product quality, regulatory risk and adverse event exposure. It also identifies several key emerging trends in QMS.
The series will cover critical issues facing Life Science manufacturers:
- Do Current QMS Implementations Meet the Challenges Facing Life Science Manufacturing Today?
- Compliance Does Not Equal Quality
- QMS in the Global Ecosystem
- Closing the Loop on QMS
Additional Resources:
Axendia Research Alert Research Shows Adverse Events Increase Despite QMS Implementations
More about Axendia - Trusted Advisors to Life Science Executives
Axendia is a leading strategic advisory firm focused on the Life Science and Healthcare markets. Our Mission is to be the most trusted advisor to Life Science Executives on Business, Regulatory and Technology issues. We serve the complete Life Science Ecosystem including Life Science Organizations, Technology & Service Providers and the Investment community.
www.axendia.com